Recommendations for detection, prioritization, and treatment of thoracic oncology patients during the COVID-19 pandemic: the THOCOoP cooperative group

Autor: Arrieta, O, Cardona, AF, Lara-Mejia, L, Heredia, D, Barron, F, Zatarain-Barron, ZL, Lozano, F, de Lima, VC, Maldonado, F, Corona-Cruz, F, Ramos, M, Cabrera, L, Martin, C, Corrales, L, Cuello, M, Arroyo-Hernandez, M, Aman, E, Bacon, L, Baez, R, Benitez, S, Botero, A, Burotto, M, Caglevic, C, Ferraris, G, Freitas, H, Kaen, DL, Lamot, S, Lyons, G, Mas, L, Mata, A, Mathias, C, Munoz, A, Patane, AK, Oblitas, G, Pino, L, Raez, LE, Remon, J, Rojas, L, Rolfo, C, Ruiz-Patino, A, Samtani, S, Viola, L, Viteri, S, Rosell, R

Publikováno v: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname

The world currently faces a pandemic due to SARS-CoV-2. Relevant information has emerged regarding the higher risk of poor outcomes in lung cancer patients. As such, lung cancer patients must be prioritized in terms of prevention, detection and treat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::6045e81a293386d2017b06668b8c8b3a
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=4218

Recommendations for detection, prioritization, and treatment of thoracic oncology patients during the COVID-19 pandemic: the THOCOoP cooperative group.

Autor: Arrieta O; Instituto Nacional de Cancerología, Mexico City, Mexico. Electronic address: oscararrietaincan@gmail.com., Cardona AF; Thoracic Oncology Clinic, Clínica del Country, Bogotá, Colombia; Foundation for Clinical and Applied Cancer Research, Bogotá, Colombia., Lara-Mejía L; Instituto Nacional de Cancerología, Mexico City, Mexico., Heredia D; Instituto Nacional de Cancerología, Mexico City, Mexico., Barrón F; Instituto Nacional de Cancerología, Mexico City, Mexico., Zatarain-Barrón ZL; Instituto Nacional de Cancerología, Mexico City, Mexico., Lozano F; Instituto Nacional de Cancerología, Mexico City, Mexico., de Lima VC; Departamento de Oncologia Clínica - A C Camargo Cancer Center, São Paulo, Brazil., Maldonado F; Instituto Nacional de Cancerología, Mexico City, Mexico., Corona-Cruz F; Instituto Nacional de Cancerología, Mexico City, Mexico., Ramos M; Instituto Nacional de Cancerología, Mexico City, Mexico., Cabrera L; Instituto Nacional de Cancerología, Mexico City, Mexico., Martin C; Thoracic Oncology Unit, Alexander Fleming Institute, Buenos Aires, Argentina; Hospital Maria Ferrer, Buenos Aires, Argentina., Corrales L; Oncology Department, Hospital San Juan de Dios, San José Costa Rica, Costa Rica; Oncología Médica, Centro de Investigación y Manejo del Cáncer (CIMCA), San José, Costa Rica., Cuello M; Department of Oncology, Hospital de Clínicas, Universidad de la República - UDELAR, Montevideo, Uruguay., Arroyo-Hernández M; Instituto Nacional de Cancerología, Mexico City, Mexico., Aman E; Clinical Oncology Unit, Swiss Medical Group, Buenos Aires, Argentina., Bacon L; Centro de Oncología, Hospital Vivián Pellas, Nicaragua., Baez R; National Institute for Respiratory Diseases, Mexico City, Mexico., Benitez S; Coordinador de la sección Oncología, asociación Argentina de Medicina Respiratoria, Argentina., Botero A; Hospital La Católica Goicoechea, San José, Costa Rica., Burotto M; Clínica Universidad de los Andes, Centro de Estudios Clínicos Bradford Hill, Chile., Caglevic C; Departamento de Investigación del Cáncer- Fundación Arturo López Pérez, Santiago, Chile., Ferraris G; Centro Médico Dean Funes, Radioterapia Oncológica, Córdoba, Argentina., Freitas H; Departamento de Oncologia Clínica - A C Camargo Cancer Center, São Paulo, Brazil., Kaen DL; Centro Oncológico Riojano Integral, La Rioja, Argentina., Lamot S; CONCIENCIA, Instituto Oncohematológico de la Patagonia, Chile., Lyons G; Department of Thoracic Surgery, Hospital Británico, Buenos Aires, Argentina., Mas L; Medical Oncology Department, National Institute for Neoplastic Diseases - INEN, Lima, Peru., Mata A; Hospital La Católica Goicoechea, San José, Costa Rica., Mathias C; NOB/Oncoclínicas, Salvador BA, Brazil., Muñoz A; Fundación Santa Fe de Bogotá, Bogotá, Colombia., Patane AK; Hospital de Rehabilitacion Respiratoria María Ferrer, Buenos Aires, Argentina., Oblitas G; Unidad Oncológica Molecular Peruana, Lima, Perú., Pino L; Medical Oncology Group, Fundación Santa Fe de Bogotá, Bogotá, Colombia., Raez LE; Thoracic Oncology Program Memorial Cancer Institute, Memorial Healthcare System, Pembroke Pines, FL, United States., Remon J; Medical Oncology Department, Centro Integral Oncología Clara Campal Bacelona, HM-Delfos, Barcelona, Spain., Rojas L; Medical Oncology Department, Clínica Colsanitas, Bogotá, Colombia., Rolfo C; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, Maryland, United States., Ruiz-Patiño A; Foundation for Clinical and Applied Cancer Research, Bogotá, Colombia., Samtani S; Medical Oncology Department, Clínica Bradford Hill, Santiago, Chile., Viola L; Fundación neumológica colombiana, Bogotá, Colombia., Viteri S; Instituto Oncológico Dr. Rosell. Centro Médico Teknon. Grupo QuironSalud. Barcelona, España., Rosell R; Cancer Biology and Precision Medicine Program, Catalan Institute of Oncology, Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain.

Publikováno v: Critical reviews in oncology/hematology [Crit Rev Oncol Hematol] 2020 Sep; Vol. 153, pp. 103033. Date of Electronic Publication: 2020 Jun 20.